Anteris Technologies Global Corp. Research and Development Expense
Anteris Technologies Global Corp. (AVR) reported Research and Development Expense of $23.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-11
- Anteris Technologies Global Corp. research and development expense for the quarter ending 2026-06-30 was $23.37M, a 43.02% increase year-over-year.
- Anteris Technologies Global Corp. research and development expense for the quarter ending 2026-03-31 was $17.46M, a 6.08% increase year-over-year.
- Anteris Technologies Global Corp. research and development expense for the quarter ending 2025-12-31 was $19.51M, a 46.55% increase year-over-year.
- Anteris Technologies Global Corp. research and development expense for the quarter ending 2025-09-30 was $16.81M, a 20.54% increase year-over-year.
- Anteris Technologies Global Corp. research and development expense for fiscal 2025 was $69.12M, a 34.34% increase from fiscal 2024.
- Anteris Technologies Global Corp. research and development expense for fiscal 2024 was $51.45M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.37M 10-Q · filed 2026-08-11 | $40.83M 10-Q · filed 2026-08-11 | $60.34M derived: sum of 3 quarters · filed 2026-08-11 | $77.15M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $17.46M 10-Q · filed 2026-05-12 | $36.97M derived: sum of 2 quarters · filed 2026-05-12 | $53.78M derived: sum of 3 quarters · filed 2026-05-12 | $70.12M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $19.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $36.32M derived: sum of 2 quarters · filed 2026-02-26 | $52.66M derived: sum of 3 quarters · filed 2026-08-11 | $69.12M 10-K · filed 2026-02-26 |
| 2025-09-30 | $16.81M 10-Q · filed 2025-11-12 | $33.15M derived: sum of 2 quarters · filed 2026-08-11 | $49.61M 10-Q · filed 2025-11-12 | $62.92M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $16.34M 10-Q · filed 2026-08-11 | $32.80M 10-Q · filed 2026-08-11 | $46.11M derived: sum of 3 quarters · filed 2026-08-11 | $60.06M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $16.46M 10-Q · filed 2026-05-12 | $29.77M derived: sum of 2 quarters · filed 2026-05-12 | $43.72M derived: sum of 3 quarters · filed 2026-05-12 | $56.35M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $13.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $27.26M derived: sum of 2 quarters · filed 2026-02-26 | $39.90M derived: sum of 3 quarters · filed 2026-02-26 | $51.45M 10-K · filed 2026-02-26 |
| 2024-09-30 | $13.95M 10-Q · filed 2025-11-12 | $26.58M derived: sum of 2 quarters · filed 2025-11-12 | $38.13M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $12.63M 10-Q · filed 2025-08-11 | $24.19M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $11.56M 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B |